TARRYTOWN, N.Y., Aug. 22,
2024 /PRNewswire/ -- Aerolase Corp. was just named
again to the annual Inc. 5000 list of America's fastest-growing
private companies in revenues. In the 2024 list, it is #23 in
healthcare products, up from #139 when the company debuted in Inc.,
and #1516 among the 5000, up from #2020 in its debut. The ranking
rise comes despite growing off of a much larger revenue base.
After the very strong growth in 2023, Aerolase is tracking
similarly in 2024. "It is gratifying to see that our lasers'
unique efficacies, versatility, and high performance with safety on
all skin tones are resonating with consumers and practitioners
alike," said Pavel Efremkin, CEO of Aerolase. This year, an
independent consulting firm's Voice of Customer survey found that
Aerolase achieved a Net Promoter Score (NPS) of 85, an
extraordinarily high metric in any industry.
Major drivers of Aerolase's recent growth include excellence in
acne treatment, unique versatility of efficacious treatment range,
and uncommonly high ROI to users in the main industry segments:
dermatologists, plastic surgeons, and the most rapidly growing
segment, medspas. Another key contributor is Aerolase lasers'
unique safety and efficacy to be combined in the same treatment
session with aesthetic injectables – toxins, fillers, and others.
This enables aesthetic clinics to offer proprietary, differentiated
services and optimize practice throughput.
A recent peer-reviewed study underlines Aerolase excellence in
acne via its Neo Elite® laser. Presented at the American
Society of Laser Medicine & Surgery, and accepted for
publication in a prominent peer-reviewed journal, this study by
Nazanin Saedi, MD, a laser
dermatologist key opinion leader, noted:
…an 85% reduction in acne lesion count at the
end of the treatment course and 87% 30 days afterward.
The 650–microsecond, pulsed 1064–nm Nd:YAG laser [the Neo
Elite®] achieves long–lasting improvement of mild to severe
facial acne vulgaris with high subject satisfaction and
without adverse effects.
Testimonial to the special attraction of Aerolase for same
session combination treatments comes from, among others,
Roberta Del Campo, MD, a laser
luminary and the founder of Del Campo Dermatology and Laser
Institute in Miami.
Combining safe and pain-free Aerolase laser
treatments with injectables and other skin rejuvenation
modalities allows me to effectively and efficiently get
great outcomes with no patient downtime. This is a key factor
that makes my practice stand out.
About Aerolase
Aerolase is the first to market in a new product category
created by Aerolase: portable, highly versatile all-skin type
dermatology and aesthetic lasers. These lasers deliver proven top
patient efficacy on a wide range of aesthetic and medical
dermatological skin conditions coupled with unmatched practitioner
ROI.
Contact:
Gary M. Giblen
Director, Competitive and Market Analysis
information@aerolase.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aerolase-extends-strong-performance-and-share-gains-recognized-in-inc-5000-302229135.html
SOURCE Aerolase